Antimicrobial resistance pattern of the Bacteroides fragilis group strains isolated at a teaching hospital in China
Acta Microbiologica et Immunologica Hungarica · 2025
DOI: 10.1556/030.2025.02400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2025. Verfasst von Zhi Cheng Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1Laboratory Department, The First Affiliated Hospital of Hainan Medical University, Haikou, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteroides fragilis, Bacteroides Infections, Drug Resistance, Bacterial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of Hainan Province, Colleges and Universities Scientific Research Projects of the Education Department of Hainan Province.
Abstract (Originalsprache)
The study was conducted in the microbiology laboratory of the First Affiliated Hospital of Hainan Medical University, Haikou, China, from January 2019 to December 2023. A total of 316 consecutive non-duplicate isolates were collected and identified, that belonged to the Bacteroides fragilis group. Identification of the isolated strains was performed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). The minimum inhibitory concentration (MIC) of seven antibiotics was determined by agar dilution method. The presence of cfiA , ermF , and nim genes was determined by polymerase chain reaction (PCR). Correlations between the presence of resistance genes and the MIC values of antibiotics were determined using the Pearson correlation coefficient. In the identification process, 214 isolates (67.7%) were identified as B. fragilis , 52 (16.4%) as Bacteroides thetaiotaomicron , 17 (5.4%) as Bacteroides ovatus , 12 (3.8%) as Bacteroides uniformis , 10 (3.2%) as Phocaeicola vulgatus (= Bacteroides vulgatus ), 7 (2.2%) as Bacteroides stercoris , and 4 (1.3%) as Parabacteroides distasonis . The presence of cfiA gene moderately correlated with the MIC of imipenem and meropenem ( r = 0.34 and r = 0.42, respectively), while resistance to clindamycin and the presence of ermF gene exhibited a very strong correlation ( r = 0.72). In the current study, the most active antimicrobial agents against B. fragilis group bacteria were found to be meropenem, imipenem, metronidazole, and piperacillin/tazobactam; however, resistance to clindamycin renders its empirical use inappropriate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Laboratory Department, The First Affiliated Hospital of Hainan Medical University, Haikou, China.
- 2Hainan Vocational University of Science and Technology, Haikou, China.
- 3Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University, Haikou, China.
- 4Department of Nephrology, Sanya People's Hospital, Sanya, China.
- 5Haikou Market Supervision Administration, Haikou, China.
ORCID-Profile: Lin Wu
Förderung
- National Natural Science Foundation of Hainan Province
- Colleges and Universities Scientific Research Projects of the Education Department of Hainan Province
Zitieren
APA
Wu, Z. C., Feng, H. X., Wu, L., Zhang, M., & Gu, Z. (2025). Antimicrobial resistance pattern of the Bacteroides fragilis group strains isolated at a teaching hospital in China. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2025.02400
Vancouver
Wu ZC, Feng HX, Wu L, Zhang M, Gu Z. Antimicrobial resistance pattern of the Bacteroides fragilis group strains isolated at a teaching hospital in China. Acta Microbiologica et Immunologica Hungarica. 2025. doi:10.1556/030.2025.02400
BibTeX
@article{Wu2025,
author = {Wu, Zhi Cheng and Feng, Hong Xin and Wu, Lin and Zhang, Meng and Gu, Zheng},
title = {Antimicrobial resistance pattern of the Bacteroides fragilis group strains isolated at a teaching hospital in China},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2025},
doi = {10.1556/030.2025.02400}
}
EUVIMED